InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
5
T+90 hit rate
0%
T+90 mean return
-6.7%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Olson Eric R, Directeur Scientifique. Officer active across 1 company, notably Syros Pharmaceuticals, Inc.. Aggregated, 7 reports have been logged. Split: 0 buy · 5 sells. Total volume traded: €27k. Activity tracked since 1 July 2021. The latest transaction was disclosed on 17 July 2023 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations7 total
689 shares@ US$3.504.0% of flowCommon StockSEC:0001209191-23-042669:0
2,000 sharesCommon StockSEC:0001209191-23-022970:0
27,266 shares@ US$1.1253.0% of flowCommon StockSEC:0001209191-22-022503:0
2,208 shares@ US$3.466912.5% of flowCommon StockSEC:0001209191-22-002216
2,208 shares@ US$3.466913.0% of flowCommon StockSEC:0001209191-22-002216:0
1,164 shares@ US$5.5510.1% of flowCommon StockSEC:0001209191-21-044493
1,164 shares@ US$5.5510.5% of flowCommon StockSEC:0001209191-21-044493:0
7 of 7 declarations
About Olson Eric R
Eric R. Olson is the Chief Scientific Officer at Syros Pharmaceuticals, Inc. He is responsible for leading the company's research and development efforts. With a strong background in the pharmaceutical field, he plays a key role in innovation and the discovery of new treatments. Syros Pharmaceuticals focuses on developing targeted therapies for genetic diseases and cancer.
